Regional age-related changes of neuromelanin and iron in the substantia nigra based on neuromelanin accumulation and iron deposition

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  T. Sarna,et al.  Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role , 2022, IUBMB life.

[3]  C. Beaulieu,et al.  R2* and quantitative susceptibility mapping in deep gray matter of 498 healthy controls from 5 to 90 years , 2021, Human brain mapping.

[4]  S. Lehéricy,et al.  The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease , 2021, Brain : a journal of neurology.

[5]  S. Lehéricy,et al.  Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker , 2021, Movement disorders : official journal of the Movement Disorder Society.

[6]  M. Calero,et al.  The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration , 2020, Antioxidants.

[7]  Daniel E. Huddleston,et al.  Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease , 2020, NeuroImage: Clinical.

[8]  P. Vitali,et al.  Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease. , 2020, Radiology.

[9]  Yu Liu,et al.  Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence , 2020, NeuroImage.

[10]  D. Reutens,et al.  Field strength influences on gradient recalled echo MRI signal compartment frequency shifts. , 2020, Magnetic resonance imaging.

[11]  K. Poston,et al.  MRI biomarkers of motor and non-motor symptoms in Parkinson's disease. , 2020, Parkinsonism & related disorders.

[12]  R. Nunes,et al.  Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease. , 2020, Journal of Huntington's disease.

[13]  Xiaoping Hu,et al.  Characterization of age-related microstructural changes in locus coeruleus and substantia nigra pars compacta , 2019, Neurobiology of Aging.

[14]  M. Cosottini,et al.  Quantitative susceptibility mapping in atypical Parkinsonisms , 2019, NeuroImage: Clinical.

[15]  P. Kaeser,et al.  Mechanisms and regulation of dopamine release , 2019, Current Opinion in Neurobiology.

[16]  Anissa Abi-Dargham,et al.  Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain , 2019, Proceedings of the National Academy of Sciences.

[17]  C. Zhong,et al.  Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease , 2019, Front. Neurol..

[18]  D. Auer,et al.  Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI , 2018, Movement disorders : official journal of the Movement Disorder Society.

[19]  S. Aoki,et al.  Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[20]  D. Sulzer,et al.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson’s disease , 2018, npj Parkinson's Disease.

[21]  Chunlei Liu,et al.  Longitudinal atlas for normative human brain development and aging over the lifespan using quantitative susceptibility mapping , 2018, NeuroImage.

[22]  Wei Zhou,et al.  Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping , 2018, Journal of the Neurological Sciences.

[23]  D. Dickson,et al.  Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[24]  Xiao Luo,et al.  Different iron deposition patterns in early- and middle-late-onset Parkinson's disease. , 2017, Parkinsonism & related disorders.

[25]  Tadeusz Sarna,et al.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease , 2017, Progress in Neurobiology.

[26]  Nian Wang,et al.  Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.

[27]  A. Ascherio,et al.  The epidemiology of Parkinson's disease: risk factors and prevention , 2016, The Lancet Neurology.

[28]  Shigeyoshi Saito,et al.  Quantitative T1, T2, and T2* Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain , 2016, PloS one.

[29]  L. Grinberg,et al.  Three-dimensional and stereological characterization of the human substantia nigra during aging , 2016, Brain Structure and Function.

[30]  R. Nunes,et al.  Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early‐stage Parkinson's disease , 2016, European journal of neurology.

[31]  Yi Wang,et al.  Age and sex related differences in subcortical brain iron concentrations among healthy adults , 2015, NeuroImage.

[32]  Jianrong Xu,et al.  Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range , 2015, NMR in biomedicine.

[33]  Carlos Ortiz-de-Solorzano,et al.  Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[34]  Tsutomu Okada,et al.  Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility , 2015, Investigative radiology.

[35]  Cyril Poupon,et al.  7 tesla magnetic resonance imaging: A closer look at substantia nigra anatomy in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[36]  Christian Langkammer,et al.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.

[37]  Shinya Fujii,et al.  Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies , 2013, Neuroradiology.

[38]  M. Mukaka,et al.  Statistics corner: A guide to appropriate use of correlation coefficient in medical research. , 2012, Malawi medical journal : the journal of Medical Association of Malawi.

[39]  T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2012 .

[40]  Dorothee P Auer,et al.  T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[41]  J. Connor,et al.  Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.

[42]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[43]  N. Turro,et al.  New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals , 2008, Proceedings of the National Academy of Sciences.

[44]  Susan M. Resnick,et al.  Morphometry of the human substantia nigra in ageing and Parkinson’s disease , 2008, Acta Neuropathologica.

[45]  C. Adler,et al.  Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits , 2007, Acta Neuropathologica.

[46]  Yasuo Terayama,et al.  Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease , 2006, Neuroreport.

[47]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[48]  L. Zecca,et al.  Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability , 2006, Journal of Neural Transmission.

[49]  J. Andersen,et al.  Cell in focusDopaminergic neurons , 2005 .

[50]  P. Riederer,et al.  Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease , 2005, Progress in Neurobiology.

[51]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[52]  Alberto Gatti,et al.  The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease , 2002, FEBS letters.

[53]  M Gallorini,et al.  Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.

[54]  L. Greene,et al.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. Xia,et al.  Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. , 1996, Chemical research in toxicology.

[56]  Matthew J. Betts,et al.  The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease , 2017, Brain : a journal of neurology.

[57]  Angelo Antonini,et al.  Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease. , 2017, Journal of Parkinson's disease.

[58]  北尾 慎一郎,et al.  Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies , 2014 .

[59]  E. Esposito,et al.  Birth, life and death of dopaminergic neurons in the substantia nigra. , 2009, Journal of neural transmission. Supplementum.

[60]  D. A. Kenny,et al.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.